Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | CYTK | SYRE | ||
| Company | Protagonist Therapeutics Inc | Cytokinetics | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 136.90 | 79.77 | 99.38 | ||
| High | 137.43 | 80.34 | 100.99 | ||
| Low | 132.72 | 78.07 | 94.52 | ||
| Latest | 133.00 | 78.39 | 97.87 | ||
| Change | -3.84 | -1.06 | -2.09 | ||
| % Change | -2.81% | -1.34% | -2.09% | ||
| Volume | 560,600 | 1,780,800 | 1,216,600 | ||
| 20-Day Average Volume | 706,505 | 1,747,735 | 1,173,390 | ||
| Previous Close | 136.84 | 79.45 | 99.96 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 134.64 | 82.48 | 96.93 | ||
| 20-Day Raw Stochastic | 50.55% | 3.16% | 63.76% | ||
| 20-Day Relative Strength | 57.11 | 47.73 | 56.11 | ||
| Weighted Alpha | +122.58 | +62.29 | +397.72 | ||
| Today's Opinion | 88% Buy | 64% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.80% since 07/22/26 | -4.63% since 07/22/26 | -1.31% since 07/22/26 | ||
| Low | 132.00 on 07/23/26 | 78.07 on 07/29/26 | 92.37 on 07/28/26 | ||
| High | 139.92 on 07/27/26 | 82.99 on 07/23/26 | 105.05 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | +9.35% since 06/29/26 | -10.17% since 06/29/26 | +8.55% since 06/29/26 | ||
| Low | 119.57 on 06/30/26 | 78.07 on 07/29/26 | 85.17 on 07/02/26 | ||
| High | 143.29 on 07/20/26 | 88.31 on 06/30/26 | 105.09 on 07/14/26 | ||
| 3-Month | |||||
| %Chg | +35.00% since 04/29/26 | +31.56% since 04/29/26 | +36.14% since 04/29/26 | ||
| Low | 92.75 on 06/02/26 | 59.69 on 04/30/26 | 64.67 on 05/19/26 | ||
| High | 143.29 on 07/20/26 | 88.31 on 06/30/26 | 105.09 on 07/14/26 | ||
| 6-Month | |||||
| %Chg | +66.81% since 01/29/26 | +19.49% since 01/29/26 | +191.45% since 01/29/26 | ||
| Low | 77.00 on 02/23/26 | 58.43 on 03/13/26 | 30.92 on 02/04/26 | ||
| High | 143.29 on 07/20/26 | 88.31 on 06/30/26 | 105.09 on 07/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,800,316 | 9,886,201 | 8,790,081 | ||
| Shares Outstanding, K | 64,311 | 124,433 | 87,936 | ||
| Annual Sales | 46,020,000 | 88,040,000 | 0 | ||
| Annual Net Income | -130,150,000 | -784,960,000 | -155,200,000 | ||
| Last Quarter Sales | 56,370,000 | 19,360,000 | 0 | ||
| Last Quarter Net Income | 3,780,000 | -206,030,000 | -69,010,000 | ||
| 60-Month Beta | 1.79 | 0.42 | 3.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 05/05/26 | -1.67 on 05/05/26 | -0.74 on 05/05/26 | ||
| Earnings Date | 08/05/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||